@article{Gülcü Taşkın_Gülseren_2023, title={Retrospective analyses of antibody titers in the diagnosis of pediatric Celiac Disease: Antibody titers in the diagnosis of pediatric Celiac Disease }, volume={10}, url={https://medscidiscovery.com/index.php/msd/article/view/912}, DOI={10.36472/msd.v10i3.912}, abstractNote={<p><strong>Objective: </strong>We aimed to evaluate the relationship between Tissue Transglutaminase IgA titer (tTGIgA) and Endomisium antibody (EMA) positivity and the stage of duodenal mucosal damage at Celiac disease (CD).</p> <p><strong>Material and Methods:</strong> The study group consisted of 233 children (2-18 years old) who were diagnosed with CD and admitted to our XXX Hospital, Pediatric Gastroenterology Outpatient Clinic, between September 2017 and November 2022. All patients underwent an endoscopy, and a histopathological diagnosis was made. In upper gastrointestinal endoscopy, one biopsy sample were taken from the duodenum bulb and four samples from the second part of the duodenum. Histological patterns were evaluated according to the Marsh-Oberhuber classification.</p> <p><strong>Results:</strong> A total 233 patients with CD were included in the study. The mean age of the patients at the time of diagnosis was 97.0 ± 57.1 months. The patients’ mean tissue transglutaminase (tTG) IgA value was 172 ± 133. The most common Marsh-Oberhuber classification was found to be Marsh 3b (47.6%) in CD patients. According to the Marsh-Oberhuber classification, the mean tTGIgA values were significantly different compared to the groups.</p> <p><strong>Conclusion:</strong> We recommend starting a diet with a diagnosis of CD without endoscopy for patients with a tTGIgA value of 10 X ULN (upper limit of normal) or more recommended by ESPGAN, and we even support randomized prospective studies to reduce this value to 7-10 times or less.</p>}, number={3}, journal={Medical Science and Discovery}, author={Gülcü Taşkın, Didem and Gülseren, Arzu}, year={2023}, month={Mar.}, pages={182–186} }